Homogenous Generation of Dopaminergic Neurons from Multiple HiPSC Lines by Transient Expression of Transcription Factors

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2019 Nov 29

PMID 31776327

Citations 31

Authors

Sameehan Mahajani

Anupam Raina

Claudia Fokken

Sebastian Kugler

Mathias Bahr

Affiliations

Soon will be listed here.

Abstract

A major hallmark of Parkinson's disease is loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). The pathophysiological mechanisms causing this relatively selective neurodegeneration are poorly understood, and thus experimental systems allowing to study dopaminergic neuron dysfunction are needed. Induced pluripotent stem cells (iPSCs) differentiated toward a dopaminergic neuronal phenotype offer a valuable source to generate human dopaminergic neurons. However, currently available protocols result in a highly variable yield of dopaminergic neurons depending on the source of hiPSCs. We have now developed a protocol based on HBA promoter-driven transient expression of transcription factors by means of adeno-associated viral (AAV) vectors, that allowed to generate very consistent numbers of dopaminergic neurons from four different human iPSC lines. We also demonstrate that AAV vectors expressing reporter genes from a neuron-specific hSyn1 promoter can serve as surrogate markers for maturation of hiPSC-derived dopaminergic neurons. Dopaminergic neurons differentiated by transcription factor expression showed aggravated neurodegeneration through α-synuclein overexpression, but were not sensitive to γ-synuclein overexpression, suggesting that these neurons are well suited to study neurodegeneration in the context of Parkinson's disease.

Citing Articles

Sustaining Brain Youth by Neural Stem Cells: Physiological and Therapeutic Perspectives.

Santos M, Moreira J, Santos S, Sola S Mol Neurobiol. 2025; .

PMID: 39985708 DOI: 10.1007/s12035-025-04774-z.

The Neuroanatomy of Induced Pluripotent Stem Cells: In Vitro Models of Subcortical Nuclei in Neurodegenerative Disorders.

Galgani A, Scotto M, Giorgi F Curr Issues Mol Biol. 2024; 46(9):10180-10199.

PMID: 39329959 PMC: 11430477. DOI: 10.3390/cimb46090607.

Ergothioneine-Mediated Neuroprotection of Human iPSC-Derived Dopaminergic Neurons.

Leow D, Cheah I, Chen L, Ng Y, Yeo C, Halliwell B Antioxidants (Basel). 2024; 13(6).

PMID: 38929132 PMC: 11200999. DOI: 10.3390/antiox13060693.

Neuronal Cell Differentiation of iPSCs for the Clinical Treatment of Neurological Diseases.

Lee D, Lee E, Lee J, Lee M, Shim J, Oh J Biomedicines. 2024; 12(6).

PMID: 38927557 PMC: 11201423. DOI: 10.3390/biomedicines12061350.

Transcription Factor-Mediated Generation of Dopaminergic Neurons from Human iPSCs-A Comparison of Methods.

McDonald K, Lyons N, Gray L, Xu J, Schoderboeck L, Hughes S Cells. 2024; 13(12.

PMID: 38920646 PMC: 11201854. DOI: 10.3390/cells13121016.

References

Sundberg M, Bogetofte H, Lawson T, Jansson J, Smith G, Astradsson A . Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Stem Cells. 2013; 31(8):1548-62. PMC: 3775937. DOI: 10.1002/stem.1415. View

Vazin T, Ball K, Lu H, Park H, Ataeijannati Y, Head-Gordon T . Efficient derivation of cortical glutamatergic neurons from human pluripotent stem cells: a model system to study neurotoxicity in Alzheimer's disease. Neurobiol Dis. 2013; 62:62-72. PMC: 4122237. DOI: 10.1016/j.nbd.2013.09.005. View

Kirkeby A, Grealish S, Wolf D, Nelander J, Wood J, Lundblad M . Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep. 2012; 1(6):703-14. DOI: 10.1016/j.celrep.2012.04.009. View

Arenas E, Denham M, Villaescusa J . How to make a midbrain dopaminergic neuron. Development. 2015; 142(11):1918-36. DOI: 10.1242/dev.097394. View

Beevers J, Lai M, Collins E, Booth H, Zambon F, Parkkinen L . MAPT Genetic Variation and Neuronal Maturity Alter Isoform Expression Affecting Axonal Transport in iPSC-Derived Dopamine Neurons. Stem Cell Reports. 2017; 9(2):587-599. PMC: 5549835. DOI: 10.1016/j.stemcr.2017.06.005. View

Taschenberger G, Garrido M, Tereshchenko Y, Bahr M, Zweckstetter M, Kugler S . Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons. Acta Neuropathol. 2011; 123(5):671-83. PMC: 3316935. DOI: 10.1007/s00401-011-0926-8. View

Ishikawa T, Imamura K, Kondo T, Koshiba Y, Hara S, Ichinose H . Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders. Hum Mol Genet. 2016; 25(23):5188-5197. PMC: 5886044. DOI: 10.1093/hmg/ddw339. View

Kugler S, Hahnewald R, Garrido M, Reiss J . Long-term rescue of a lethal inherited disease by adeno-associated virus-mediated gene transfer in a mouse model of molybdenum-cofactor deficiency. Am J Hum Genet. 2007; 80(2):291-7. PMC: 1785341. DOI: 10.1086/511281. View

Xi J, Liu Y, Liu H, Chen H, Emborg M, Zhang S . Specification of midbrain dopamine neurons from primate pluripotent stem cells. Stem Cells. 2012; 30(8):1655-63. PMC: 3405174. DOI: 10.1002/stem.1152. View

10.

Romero-Moya D, Santos-Ocana C, Castano J, Garrabou G, Rodriguez-Gomez J, Ruiz-Bonilla V . Genetic Rescue of Mitochondrial and Skeletal Muscle Impairment in an Induced Pluripotent Stem Cells Model of Coenzyme Q Deficiency. Stem Cells. 2017; 35(7):1687-1703. DOI: 10.1002/stem.2634. View

11.

Doi D, Samata B, Katsukawa M, Kikuchi T, Morizane A, Ono Y . Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Reports. 2014; 2(3):337-50. PMC: 3964289. DOI: 10.1016/j.stemcr.2014.01.013. View

12.

Sheng Y, Filichia E, Shick E, Preston K, Phillips K, Cooperman L . Using iPSC-derived human DA neurons from opioid-dependent subjects to study dopamine dynamics. Brain Behav. 2016; 6(8):e00491. PMC: 4884574. DOI: 10.1002/brb3.491. View

13.

Hsu C, Li H, Hung Y, Leu Y, Wu W, Wang F . Targeted methylation of CMV and E1A viral promoters. Biochem Biophys Res Commun. 2010; 402(2):228-34. DOI: 10.1016/j.bbrc.2010.09.131. View

14.

Chung S, Leung A, Han B, Chang M, Moon J, Kim C . Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway. Cell Stem Cell. 2009; 5(6):646-58. PMC: 2788512. DOI: 10.1016/j.stem.2009.09.015. View

15.

Zahur M, Tolo J, Bahr M, Kugler S . Long-Term Assessment of AAV-Mediated Zinc Finger Nuclease Expression in the Mouse Brain. Front Mol Neurosci. 2017; 10:142. PMC: 5440507. DOI: 10.3389/fnmol.2017.00142. View

16.

Chambers S, Fasano C, Papapetrou E, Tomishima M, Sadelain M, Studer L . Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009; 27(3):275-80. PMC: 2756723. DOI: 10.1038/nbt.1529. View

17.

Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A . Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997; 276(5321):2045-7. DOI: 10.1126/science.276.5321.2045. View

18.

Friling S, Andersson E, Thompson L, Jonsson M, Hebsgaard J, Nanou E . Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci U S A. 2009; 106(18):7613-8. PMC: 2671325. DOI: 10.1073/pnas.0902396106. View

19.

Surmeier D, Obeso J, Halliday G . Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci. 2017; 18(2):101-113. PMC: 5564322. DOI: 10.1038/nrn.2016.178. View

20.

Mahajani S, Giacomini C, Marinaro F, De Pietri Tonelli D, Contestabile A, Gasparini L . Lamin B1 levels modulate differentiation into neurons during embryonic corticogenesis. Sci Rep. 2017; 7(1):4897. PMC: 5501862. DOI: 10.1038/s41598-017-05078-6. View